36071-76-8 Usage
Uses
Used in Pharmaceutical Applications:
(3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one is used as a pharmaceutical agent for its anti-inflammatory, anti-fungal, and anti-tumor properties. Its chemical structure suggests that it may play a role in various biological processes, and further research on (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one could lead to the development of new drugs with therapeutic potential.
Used in Research and Development:
In the field of research and development, (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one is used as a subject of study to explore its potential applications in medicine. (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one's unique structure and properties make it an interesting candidate for the development of novel therapeutic agents.
Used in Drug Delivery Systems:
Similar to gallotannin, (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one could potentially be used in drug delivery systems to enhance its applications and efficacy. Various organic and metallic nanoparticles could be employed as carriers for (3β,5α,22E)-3-(benzoyloxy)ergosta-8(14),22-dien-15-one, aiming to improve its delivery, bioavailability, and therapeutic outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 36071-76-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,0,7 and 1 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 36071-76:
(7*3)+(6*6)+(5*0)+(4*7)+(3*1)+(2*7)+(1*6)=108
108 % 10 = 8
So 36071-76-8 is a valid CAS Registry Number.
36071-76-8Relevant academic research and scientific papers
SYNTHESE PARTIELLE DU CHROMOPHORE STEROIDIQUE AZA-14a D-HOMO DIENE-8, 14a PRESENT DANS L'ANTIBIOTIQUE A 25822 B
Barton, Derek H. R.,Lusinchi, Xavier,Menendez, Antonio Martinez,Milliet, Pierre
, p. 2201 - 2205 (2007/10/02)
Ergosterol 2 has been converted into the known 15-ketones 6 and 7 and thence, by oxime formation, Beckmann rearrangement and reduction, into the imine 16.Dehydrogenation of 16 with various high potential quinones has afforded the desired dienimine 17 with
